• Join
  • Login
  • Contact

Search abstracts

Current regulatory thinking on biosimilars

  • At: Basel (Switzerland) (2008)
  • Type: Presentation
  • By: MORRIS, Tina S. (United States Pharmacopeia (USP), Rockville, United States of America)
  • Abstract:

    A clear regulatory picture for follow-on products has emerged in Europe, based on the concepts of similarity, comparability, and non-interchangeability. EMEA guidance clearly states that the standard generic approach is not scientifically appropriate for biologics and biotechnology-derived articles. Instead, the similarity approach is taken based


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses